SeV-amyloid beta vaccine (ID Pharma/National Institute of Longevity Science)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSeV-amyloid beta vaccine (ID Pharma/National Institute of Longevity Science)
Drug Alias NameHVJ-Abeta (DNAVEC)SeV-Abeta (DNAVEC)SeV-amyloid beta DNA vaccine (DNAVEC Corporation)DNA vaccine (DNAVEC Corporation)SeV-amyloid beta RNA vaccine (DNAVEC)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesID Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Center For Geriatrics And Gerontology, JapanID Pharma Co LtdEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A